21 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
and uncertainties;
We may be negatively impacted by volatility in the political and economic environment, such as the ongoing crisis in Ukraine, economic downturns … to be successful, it is important for the uterus to be receptive to embryo implantation, which includes a proper hormonal environment, appropriate blood flow
6-K
EX-99.2
OBSVF
ObsEva SA
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
extension clinical trial, due to challenges with patient enrollment, as well as the persisting difficult environment of the ongoing pandemic. Enrollment
6-K
OBSVF
ObsEva SA
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
;
changes in a specific country's or region's political or economic environment;
trade protection measures, import or export licensing requirements or other
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges … ”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling
6-K
EX-99.2
39uae32n
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K/A
EX-99.2
qr7mzkve tde
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
7ima 7z72w
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
zaod4tm
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
vxvgwa3kqsh2
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-1.1
n21uvwapvoxt2
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-99.1
5gxertgzbgpm8n4lr1
11 Jan 21
ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
7:05am
6-K
EX-1.1
uqwr8m9fed
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
gev0314hj
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
20-F
4h73ujo
21 Apr 17
Annual report (foreign)
12:00am
F-1
26vetoh9840e 5g2d6
30 Dec 16
Registration statement (foreign)
12:00am